The role of Acticoat™ with nanocrystalline silver in the management of burns

331Citations
Citations of this article
195Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Silver is an effective antimicrobial agent, but older silver-containing formulations are rapidly inactivated by the wound environment, requiring frequent replenishment. These older formulations may also be pro-inflammatory and may delay healing. Acticoat™ (Smith & Nephew, Hull, UK) is a relatively new form of silver antimicrobial barrier dressing which helps avoid the problems of earlier agents. It has rapid and sustained bactericidal activity, and because of this may reduce inflammation and promote healing. Despite extensive testing and clinical experience, no evidence has emerged of resistance or cytotoxicity to nanocrystalline silver. This article collects together a number of presentations that were given at the 2003 European Burns Association Meeting on the use of Acticoat™ in the management of burns. © 2004 Published by Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Dunn, K., & Edwards-Jones, V. (2004). The role of ActicoatTM with nanocrystalline silver in the management of burns. Burns, 30(SUPPL. 1). https://doi.org/10.1016/S0305-4179(04)90000-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free